| Title | Biologics: Targets and Therapy |
| Standard Abbreviation | Biol.: Targets Ther. |
| Type of Publication | Journal |
| Discipline | Gastroenterology (Q1); Oncology (Q1); Pharmacology (medical) (Q1); Rheumatology (Q1); Immunology and Allergy (Q2) |
| Impact Score | 4.21 |
| SCImago Journal Rank (SJR) | 1.176 |
| h-index | 44 |
| Overall Rank | 3191 |
| Publisher Name | Dove Medical Press Ltd. |
| Publication Country | New Zealand |
| International Standard Serial Number (ISSN) | 11775491, 11775475 |
| Coverage and History | 1988, 2007-2022 |
| Best Quartile | Q1 |
| Total Citations Received (Last 3 Year) |
335 |
Biologics: Targets and Therapy is a journal published by Dove Medical Press Ltd.. This journal covers the area[s] related to Gastroenterology, Oncology, Pharmacology (medical), Rheumatology, Immunology and Allergy, etc.
The coverage history of this journal is as follows: 1988, 2007-2022.
The rank of this journal is 3191. This journal's impact score, h-index, and SJR are 4.21, 44, and 1.176, respectively. The ISSN of this journal is/are as follows: 11775491, 11775475.
The best quartile of Biologics: Targets and Therapy is Q1.
This journal has received a total of 335 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Biologics: Targets and Therapy is 4.21. It is computed in the year 2023 as per its definition and based on Scopus data.
4.21
It is decreased by a factor of around 0.93, and the percentage change is -18.09% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Biologics: Targets and Therapy is 4.21. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 4.21 |
| 2021 | 5.14 |
| 2020 | 4.44 |
| 2019 | 2.81 |
| 2018 | 2.13 |
| 2017 | 2.82 |
| 2016 | 3.74 |
| 2015 | 4.90 |
| 2014 | 4.22 |
The h-index of Biologics: Targets and Therapy is 44. By definition of the h-index, this journal has at least 44 published articles with more than 44 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Biologics: Targets and Therapy is/are as follows: 11775491, 11775475.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Biologics: Targets and Therapy is ranked 3191 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 1.176.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Biologics: Targets and Therapy is Dove Medical Press Ltd.. The publishing house of this journal is located in the New Zealand. Its coverage history is as follows: 1988, 2007-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Biologics: Targets and Therapy is Biol.: Targets Ther.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Biol.: Targets Ther.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Gastroenterology, Oncology, Pharmacology (medical), Rheumatology, Immunology and Allergy, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Biologics: Targets and Therapy is 4.21. It is computed in the year 2023.
The latest h-index of Biologics: Targets and Therapy is 44. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Biologics: Targets and Therapy is 1.176. It is calculated in the year 2023.
The latest ranking of Biologics: Targets and Therapy is 3191. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Biologics: Targets and Therapy is published by Dove Medical Press Ltd.. The publication country of this journal is New Zealand.
This standard abbreviation of Biologics: Targets and Therapy is Biol.: Targets Ther..
Biologics: Targets and Therapy is a journal published by Dove Medical Press Ltd..
The scope of Biologics: Targets and Therapy is as follows:
For detailed scope of Biologics: Targets and Therapy, check the official website of this journal.
The International Standard Serial Number (ISSN) of Biologics: Targets and Therapy is/are as follows: 11775491, 11775475.
The best quartile for Biologics: Targets and Therapy is Q1.
The coverage history of Biologics: Targets and Therapy is as follows 1988, 2007-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Journal of Business Economics and Management | Journal | Vilnius Gediminas Technical University | 10343 | 45 | 2.81 | |
| Dermatologia Kliniczna | Journal | Cornetis | 25442 | 7 | 0.00 | |
| Journal of Academic Ethics | Journal | Springer Netherlands | 8920 | 26 | 2.28 | |
| Air and Space Power Journal (discontinued) | Journal | AU Press | 28397 | 9 | 0.20 | |
| Marine Biology Research | Journal | Taylor and Francis Ltd. | 13573 | 42 | 1.06 | |
| Modern Language Journal | Journal | Wiley-Blackwell | 918 | 103 | 3.89 | |
| International Journal of Research and Method in Education | Journal | Taylor and Francis Ltd. | 5180 | 34 | 2.49 | |
| European Surgery - Acta Chirurgica Austriaca | Journal | Springer Medizin | 16873 | 23 | 0.58 | |
| Natural Solutions | Trade Journal | Innovision Health Media | 28581 | 1 | 0.00 | |
| Asian Textile Journal | Trade Journal | G P S Kwatra | 27455 | 10 | 0.01 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 4.21 |
| 2021 | 5.14 |
| 2020 | 4.44 |
| 2019 | 2.81 |
| 2018 | 2.13 |
| 2017 | 2.82 |
| 2016 | 3.74 |
| 2015 | 4.90 |
| 2014 | 4.22 |
4.21
1.176
44
3191
